CRP and Crohn disease: Risk factors for relapse included male sex, high leucocyte counts, high CRP, high FC and low levels of haemoglobin.20 The multicentre randomised CEASE trial (Diagnostic tool to safely CEASE anti-TNF therapy in Crohn's disease, ZonMw project number 848101009) will further investigate cessation of anti-TNF.